Susquehanna Fundamental Investments, LLC Opgen Inc Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.39 - $0.63 $17,940 - $28,980	-46,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.11 $2,592 - $3,996	-3,600 Reduced 7.26%	46,000 $35,000
Q4 2021 Feb 14, 2022	SELL	$1.0 - $2.94 $42,200 - $124,068	-42,200 Reduced 45.97%	49,600 $50,000
Q3 2021 Nov 15, 2021	BUY	$2.18 - $3.58 $87,636 - $143,916	40,200 Added 77.91%	91,800 $264,000
Q2 2021 Aug 11, 2021	BUY	$1.95 - $2.8 $100,620 - $144,480	51,600 New	51,600 $117,000

Q1 2021 May 17, 2021	SELL	$1.8 - $3.55 $75,240 - $148,390	-41,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.7 - $2.47 $9,690 - $14,079	5,700 Added 15.79%	41,800 $85,000
Q3 2020 Nov 16, 2020	BUY	$1.98 - $3.37 $71,478 - $121,657	36,100 New	36,100 $77,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $141M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.